Some stock data isn't available right now.
Roivant Sciences Ltd. Common Shares (ROIV)
Underlying price
$35.01-1.20% today
Stock stats
- Market cap
- $25.5B
- Previous close
- $35.44
- Open
- $34.92
- Day's range
- $34.68 – $35.41
- 52-week range
- $15.99 – $42.50
- Volume
- 917K
- Avg volume
- 9.12M
- P/E ratio
- -
About Roivant Sciences Ltd. Common Shares
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
- Ticker
- ROIV
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 721
- Website
- roivant.com